Quick Answer
Xtant Medical Holdings, Inc. reported Cash and Equivalents of $17.05 million for fiscal year 2025.
Xtant Medical Holdings, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $17.05M | +175.1% |
| 2024 | $6.20M | +8.5% |
| 2023 | $5.71M | -71.8% |
| 2022 | $20.30M | +11.3% |
| 2021 | $18.24M | +679.3% |
| 2020 | $2.34M | -55.3% |
| 2019 | $5.24M | -23.0% |
| 2018 | $6.80M | +138.0% |
| 2017 | $2.86M | +10.8% |
| 2016 | $2.58M | -59.5% |
| 2015 | $6.37M | +42.5% |
| 2014 | $4.47M | +46.7% |
| 2013 | $3.05M | -38.2% |
| 2012 | $4.93M | +555.8% |
| 2011 | $751.1K | +129.4% |
| 2010 | $327.5K | +504.7% |
| 2009 | $54.2K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.40M | +57.7% | +50.2% |
| June 30, 2025 | $6.92M | +28.7% | +37.6% |
| March 31, 2025 | $5.03M | +10.7% | -18.8% |
| December 31, 2024 | $6.20M | +8.5% | -6.0% |
| September 30, 2024 | $6.60M | -23.9% | +22.6% |
| June 30, 2024 | $5.38M | +30.0% | +18.3% |
| March 31, 2024 | $4.55M | -12.2% | -20.4% |
| December 31, 2023 | $5.71M | -71.8% | -34.0% |
- Xtant Medical Holdings, Inc. showed an increase of +175.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, Xtant Medical Holdings, Inc.’s cash and equivalents has grown by 31389.2% (from $54.2 thousand to $17.05 million).
- The most recent figure is from Xtant Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: